Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hereditary factors affect acne duration, not severity, and late-onset acne in females has different causes.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Overexpression of the HE4 gene in mice causes eye inflammation and cloudiness.

TNF-alpha inhibitors can cause various immune-related skin issues.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

New alopecia treatments aim for better results and fewer side effects.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Lokivetmab reduced itching in a dog with skin lymphoma.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Alopecia Areata might be linked to Crohn's disease.

COVID-19 infection may trigger alopecia areata in some patients.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

The substance from human hair root cells can help maintain hair growth and make skin cells more capable of growing hair.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Liaoning cashmere goats grow more cashmere by boosting fat production, supporting hair structure, and controlling inflammation.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Higher IL-17A levels indicate more severe alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.